Need a specific person's email?
Browse Inimmune's employee directory (about 36 employees) and reveal verified emails free.
Inimmune's most common email format is First.Last@inimmune.com (ex. John.Doe@inimmune.com), used for 88% of inimmune.com addresses. Inimmune uses 4 email patterns.
| Format | Example | Share of inimmune.com |
|---|---|---|
| First.Last@inimmune.comMost common | John.Doe@inimmune.com | |
| Last_First@inimmune.com | Doe_John@inimmune.com | |
| F-Last@inimmune.com | J-Doe@inimmune.com | |
| Fir.Last@inimmune.com | Joh.Doe@inimmune.com |
Browse Inimmune's employee directory (about 36 employees) and reveal verified emails free.
Biotechnology ResearchMontana, United States11-50 Employees
Inimmune is a Missoula, Montana-based clinical-stage biotechnology company founded by veterans of the pharmaceutical industry. It focuses on developing next-generation immunotherapies, including approaches to vaccine adjuvants and delivery systems that aim to improve immune responses. Operating in biotech research, the company pursues collaborations with researchers and pharmaceutical partners to advance its programs. In March 2026, Inimmune announced leadership appointments, naming Ferdinand Massari as Chief Medical Officer and Ryan McMillian as Head of Financial Strategy. The company has a history of collaborative relationships, including a 2023 research partnership with Boston Children's Hospital to explore novel vaccine adjuvants and a 2024 collaboration with SPI Pharma to develop advanced adjuvant systems for vaccines. These activities illustrate its role as a collaborative partner in immunotherapy and vaccine innovation.
Most common format
First.Last@inimmune.com
Example: John.Doe@inimmune.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.